Navigation Links
Duska Therapeutics Submits Phase 3 ATPace(TM) Protocol to FDA for Comment
Date:7/23/2008

gational medicines, two of which are in late stages of clinical testing. Duska's ATPace(TM) is expected to enter a pivotal Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia. Duska's CDP-1050 is expected to commence a Phase 2 clinical trial for the treatment of heart failure. In addition, Duska has a preclinical program to develop new chemical entities that target a newly discovered pathway in the pathophysiology of chronic obstructive pulmonary disease. For more information, visit http://www.duskatherapeutics.com.

Forward-looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended that involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The forward-looking statements are based on current expectations, estimates and projections made by management. Duska intends for the forward- looking statements to be covered by the safe harbor provisions for forward- looking statements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," or variations of such words are intended to identify such forward-looking statements. All statements in this release regarding the future outlook related to Duska are forward-looking statements, including the statements that Duska believes that the proposed single, prospective, placebo-controlled, and randomized trial in patients presenting to the emergency room with paroxysmal supraventricular tachycardia (PSVT) should be sufficient to demonstrate clinical safety and efficacy, that Duska believes that upon successful completion of the proposed Phase 3 trial, it would have all the clinical data necessary to support the filing of the NDA for ATPace(TM) under section 505(b)(2), the belief tha
'/>"/>

SOURCE Duska Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Duska Therapeutics Obtains Standard & Poors Listing
2. Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics
3. CV Therapeutics to Announce 2008 Second Quarter Financial Results on Thursday, July 31, 2008
4. Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008
5. Zenobia Therapeutics, Inc. Begins Operations as a Fragment-Based Lead Discovery Company
6. Northwest Biotherapeutics to Present at Next Generation Vaccine Conference
7. Organizational Changes at Silence Therapeutics
8. Genzyme Corporation and PTC Therapeutics Announce Collaboration on Small Molecule for Genetic Diseases
9. Arno Therapeutics Announces New Ticker Symbol
10. Lorus Therapeutics Receives $600 Thousand From Escrow Account
11. Silence Therapeutics Announces Successful Opposition of Glover Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... --  GenoSpace , a precision medicine software company that ... the broad use of genomic data in research and ... Phase I of a Fast Track Small Business Innovation ... (NIH) to enable enhanced data access and cohort construction ... During the past decade, the cost ...
(Date:9/23/2014)... SC (PRWEB) September 23, 2014 Dr. ... my third book on healthcare offers a three phase ... 21st century healthcare delivery system that would go far ... state’s responsibility regarding the delivery of healthcare.” , “Every ... safety has failed to provide discernable progress throughout that ...
(Date:9/22/2014)... treated with a statin in the hospital after suffering ... survive than those who were not, according to a ... study was conducted by the same researchers who recently ... survival in victims of ischemic stroke., Ischemic stroke is ... vessel that blocks blood from reaching areas of the ...
(Date:9/22/2014)... by researchers at the USC Viterbi School of ... 3-D microfluidic system quickly and cheaply by simply ... Microfluidic systems are used in many fields including ... volumes of fluids for use in applications such ... diagnostic testing, and synthetic chemistry. Traditionally, microfluidic devices ...
Breaking Biology Technology:GenoSpace Awarded Fast Track SBIR Grant to Enable Data Access and Cohort Construction for Biorepositories 2Dr. Ira Williams Offers the Healthcare Solution Necessary for Patient Safety Improvement 2Statin use during hospitalization for hemorrhagic stroke associated with improved survival 2Lego-like modular components make building 3-D 'labs-on-a-chip' a snap 2Lego-like modular components make building 3-D 'labs-on-a-chip' a snap 3Lego-like modular components make building 3-D 'labs-on-a-chip' a snap 4Lego-like modular components make building 3-D 'labs-on-a-chip' a snap 5
... men of action. Lies do not become us." , ,- ... business owners sometime seem like a big challenge to marketers. ... the right opportunity, however, small business owners can also be ... a desirable and growing market to many businesses. According to ...
... exodus continues at Merge Technologies, Inc. , ,The ... Healthcare, has announced that it received "a written notification from ... and president of Merge subsidiary Cedara Software , of ... 18. , ,Pedlar is the fifth executive to leave the ...
... - GE Healthcare will have the exclusive ... the terms of a 15-year agreement with its developer, ... will supply the stem cell harvesting product, known as the ... one of the world's largest chains of private umbilical cord ...
Cached Biology Technology:Big opportunities with small businesses 2Big opportunities with small businesses 3Pedlar the latest executive to leave Merge 2
(Date:9/23/2014)... today that the Company has secured $21 million in ... used to expand the Company,s cancer immunotherapy pipeline and ... Yuan Capital led the round, with participation from Majuven ... Suma Venture and Harbinger Venture Capital. , Eureka ... antibodies engineered to mimic the functions of a T ...
(Date:9/23/2014)... turn it is to do the washing up, negotiating rights ... as many students returning to university for the new academic ... house can be a tricky business. , And now research ... new technology to allow people to monitor their energy usage ... tension. , The study by a team of technology experts ...
(Date:9/23/2014)... could be as good for your mental as your ... by the University of Warwick,s Medical School using data ... BMJ Open focused on mental wellbeing and ... associated with an individual,s fruit and vegetable consumption. , ... or more portions of fruit and vegetables a day, ...
Breaking Biology News(10 mins):Smart meters could cause conflict for housemates, study shows 2Smart meters could cause conflict for housemates, study shows 3Eating five a day may keep the blues away 2
... specialized sensory organ that the malaria mosquito uses to ... of researchers has taken an important step toward developing ... used to reduce the threat of malaria, generally considered ... sensory organ is the maxillary palp. It is one ...
... at St. Jude Childrens Research Hospital provide strong evidence ... which has revolutionized the treatment of chronic myelogenous leukemia, ... particularly aggressive form of acute lymphoblastic leukemia (ALL). Targeted ... a specific molecule, a strategy aimed at making treatments ...
... may be attracted to more than the bananas that are ... carbonated water. Fruit flies detect and are attracted to the ... found on rotting fruits containing yeast, concludes a study appearing ... at the University of California, Berkeley, who conducted the study, ...
Cached Biology News:Advance in effort to fight malaria by tricking the mosquito's sense of smell 2Advance in effort to fight malaria by tricking the mosquito's sense of smell 3St. Jude finds factors that accelerate resistance to targeted therapy in lymphoblastic leukemia 2Researchers find new taste in fruit flies: carbonated water 2Researchers find new taste in fruit flies: carbonated water 3
...
Monoclonal Mouse Anti-Human Cytokeratin 16 (48 kD)...
This antibody detects cdc42 on SDS-PAGE immunoblots....
Goat polyclonal to Nebraska Calf Diarrhea Virus (FITC) ( Abpromise for all tested applications). Antigen: Bovine (Nebraska Calf Diarrhea Virus)....
Biology Products: